Wegovy's Medicare Part D Prospects: Four Million Lives And Counting?

 
• By Cathy Kelly
  
Payers worry demand for Wegovy will be much higher now that there is some access to it in Part D. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet